Assessment of the control measures for category A diseases of Animal Health Law: Contagious Caprine Pleuropneumonia.
Contagious Caprine Pleuropneumonia
Disease control measures
Mycoplasma capricolum subsp. capripneumoniae
monitoring period
protection zone
sampling procedures
surveillance zone
Journal
EFSA journal. European Food Safety Authority
ISSN: 1831-4732
Titre abrégé: EFSA J
Pays: United States
ID NLM: 101642076
Informations de publication
Date de publication:
Jan 2022
Jan 2022
Historique:
entrez:
2
2
2022
pubmed:
3
2
2022
medline:
3
2
2022
Statut:
epublish
Résumé
EFSA received a mandate from the European Commission to assess the effectiveness of some of the control measures against diseases included in the Category A list according to Regulation (EU) 2016/429 on transmissible animal diseases ('Animal Health Law'). This opinion belongs to a series of opinions where these control measures will be assessed, with this opinion covering the assessment of control measures for Contagious Caprine Pleuropneumonia (CCPP). In this opinion, EFSA and the AHAW Panel of experts review the effectiveness of: (i) clinical and laboratory sampling procedures, (ii) monitoring period, (iii) the minimum radius of the protection and surveillance zones and iv) the minimum length of time the measures should be applied in these zones. The general methodology used for this series of opinions has been published elsewhere. Several scenarios for which these control measures had to be assessed were designed and agreed prior to the start of the assessment. Different clinical and laboratory sampling procedures are proposed depending on the scenarios considered. The monitoring period of 45 days was assessed as effective in affected areas where high awareness is expected, and when the index case occurs in an area where the awareness is low the monitoring period should be at least 180 days (6 months). Since transmission kernels do not exist and data to estimate transmission kernels are not available, a surveillance zone of 3 km was considered effective based on expert knowledge, while a protection zone should also be developed to include establishments adjacent to affected ones. Recommendations, provided for each of the scenarios assessed, aim to support the European Commission in the drafting of further pieces of legislation, as well as for plausible ad hoc requests in relation to CCPP.
Identifiants
pubmed: 35106092
doi: 10.2903/j.efsa.2022.7068
pii: EFS27068
pmc: PMC8787594
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e07068Informations de copyright
© 2022 Wiley‐VCH Verlag GmbH & Co. KgaA on behalf of the European Food Safety Authority.
Références
Vet Microbiol. 2004 Nov 30;104(1-2):125-32
pubmed: 15530747
Trop Anim Health Prod. 2020 May;52(3):1179-1186
pubmed: 31705356
Prev Vet Med. 2018 Sep 1;157:70-77
pubmed: 30086851
Proteomics. 2018 Sep;18(17):e1800088
pubmed: 29911326
EFSA J. 2022 Jan 25;20(1):e07068
pubmed: 35106092
PLoS One. 2016 Apr 28;11(4):e0153688
pubmed: 27123588
BMC Vet Res. 2014 Feb 24;10:48
pubmed: 24565080
J Zoo Wildl Med. 2007 Mar;38(1):93-6
pubmed: 17469281
Rev Sci Tech. 2018 Dec;37(3):831-836
pubmed: 30964465
Vet Rec. 2005 Feb 26;156(9):286-7
pubmed: 15765900
Vaccines (Basel). 2019 Jul 23;7(3):
pubmed: 31340571
Vet Res. 2019 Feb 8;50(1):10
pubmed: 30736863
EFSA J. 2018 Jan 24;16(1):e05123
pubmed: 32625671
Rev Sci Tech. 2009 Dec;28(3):1037-44
pubmed: 20462161
Appl Environ Microbiol. 1994 Jan;60(1):149-52
pubmed: 7509584
Trop Anim Health Prod. 1990 Nov;22(4):260-2
pubmed: 2288010
Animals (Basel). 2021 Apr 19;11(4):
pubmed: 33921576
EFSA J. 2017 Oct 04;15(10):e04996
pubmed: 32625293
Heliyon. 2020 Oct 08;6(10):e05146
pubmed: 33083610
Acta Vet Scand. 2000;41(3):311-9
pubmed: 11126580
Emerg Infect Dis. 2013 Dec;19(12):2051-3
pubmed: 24274020
Acta Vet Scand. 2004;45(3-4):167-79
pubmed: 15663077
Mol Cell Probes. 2008 Oct-Dec;22(5-6):324-8
pubmed: 18678244
Vet Microbiol. 2014 Sep 17;173(1-2):156-9
pubmed: 25069622